PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.\', \'State Key Laboratory of Respiratory Disease, Guangzhou Institute of Respiratory Health, First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong Province, China.\', \'Department of ICU, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China.\', \'Department of Hematology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.\', \'School of Public Health, Sun Yat-sen University, Guangzhou, China.\', \'Department of Immunology and Inflammation, Haematology Research Centre, Imperial College London, London, UK.\', \'Department of Hematologic Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-sen University Cancer Center, Guangzhou, China. liangyang@sysucc.org.cn.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.1038/s41375-021-01264-8
?:doi
?:hasPublicationType
?:journal
  • Leukemia
is ?:pmid of
?:pmid
?:pmid
  • 34002026
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 5.131
?:rankingScore_hIndex
  • 168
is ?:relation_isRelatedTo_publication of
?:title
  • Systematic review and meta-analysis of tocilizumab in persons with coronavirus disease-2019 (COVID-19).
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all